The Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program
Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats need efficient pharmaceutical services and treatment with quality medicines.
Controlling the global hazard of antimicrobial resistance and supporting the Global Health Security Agenda rely on robust pharmaceutical systems worldwide. Funded by the US Agency for International Development (USAID) and led by MSH, the goal of the five-year USAID MTaPS program is to help low- and middle-income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines and pharmaceutical services. USAID MTaPS builds upon the work of its predecessor program, Systems for Improved Access to Pharmaceuticals and Services (SIAPS).
Program objectives are as follows:
Pharmaceutical-sector governance strengthened
Institutional and human resource capacity for pharmaceutical management and services increased, including regulation of medical products
Availability and use of pharmaceutical information for decision making increased and global learning agenda advanced
Pharmaceutical-sector financing, including resource allocation and use, optimized
Pharmaceutical services, including product availability and patient-centered care to achieve health outcomes, improved
Special focus: Supporting the Global Health Security Agenda (GHSA)
As a core part of its work in nine countries, USAID MTaPS will support USAID’s efforts under the GHSA to combat AMR, which has been identified as needing particular attention. The broader purpose of GHSA is to help build countries’ capacity to be safe from infectious disease threats and to raise global health security as national and global priorities.
If you wish to learn more about positions under the USAID MTaPS program and their job descriptions, take a look at all the current job opportunities available here.